Litcius/Paper detail

Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

María José Casanova, Berta Caballol, María José García, Francisco Mesonero, Cristina Rubín de Célix, Patricia Suárez-Álvarez, Rocío Ferreiro‐Iglesias, María del Mar Martín-Rodríguez, Ruth de Francisco, Pilar Varela-Trastoy, Guillermo Bastida, Marta Carrillo‐Palau, Andrea Núñez‐Ortiz, Patricia Ramírez-de la Piscina, Daniel Ceballos, Daniel Hervías-Cruz, Roser Muñoz-Pérez, Benito Velayos, Fernando Bermejo, David Busquets, Manuel Cabacino, Patricia Camo-Monterde, Ignacio Marín-Jiménez, M. Carmen Muñoz, Luisa de la Peña, Eva Sierra-Moros, Jésus Barrio, Eduard Brunet-Mas, Luis Bujanda, Fiorella Cañete, Fernando Gomollón, Noemí Manceñido, Iago Rodríguez–Lago, María Carmen Rodríguez-Grau, Beatriz Sicilia, Sandra Torra-Alsina, Laura Arranz-Hernández, Daniel Carpio, Mariana Fe García-Sepulcre, Carlos González‐Muñoza, José María Huguet, Lucía Márquez, María Pilar López-Serrano, Ángel Ponferrada-Díaz, María Chaparro, Javier P. Gisbert

2024Digestive and Liver Disease14 citationsDOI

Topics & Concepts

UstekinumabVedolizumabMedicineCrohn's diseasePersistence (discontinuity)DermatologyCrohn diseaseDiseaseInternal medicineAdalimumabGeotechnical engineeringEngineeringAnorectal Disease Treatments and OutcomesInflammatory Bowel DiseaseHidradenitis Suppurativa and Treatments
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU | Litcius